p27(KiP1) overexpression inhibits the growth and doxorubicin sensitivity of HT29 human colon cancer cells in vivo

Anticancer Research

Volumn 20, Issue 2 A, 2000, Pages 849-852

  Dimanche Boitrel, Marie thérèse ^a   Micheau, Olivier ^a   France, Damien ^b   Hammann, Arlette ^a   Duchamp, Olivier ^b   Genne, Philippe ^b   Solary, Eric ^a  

^a INSERM   (France)

^b Oncodesign   (France)

Author keywords

Chemoresistance; Colon cancer; Doxorubicin; Nude mice; p27(KiP1)

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; DOXORUBICIN; PROTEIN P27; CDKN1B PROTEIN, MOUSE; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; ENZYME INHIBITOR; MICROTUBULE ASSOCIATED PROTEIN; RECOMBINANT PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CARCINOGENICITY; CELL STRAIN HT29; EXPERIMENTAL NEOPLASM; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; ANIMAL; CELL DIVISION; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; METABOLISM; MOUSE; XENOGRAFT;

ANIMALS; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DOXORUBICIN; ENZYME INHIBITORS; HT29 CELLS; HUMANS; MICE; MICE, NUDE; MICROTUBULE-ASSOCIATED PROTEINS; RECOMBINANT PROTEINS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR SUPPRESSOR PROTEINS;

EID: 0033625689     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. KiP1. Cell 85: 721-732,1996.
2. KiP1 -deficient mice. Cell 85: 733-744,1996.
3. KiP1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85: 707-720, 1996.
4. KiP1, to regions involved in human cancer. Cancer Res 55: 1199-1205, 1995.
5. KiP1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res 55: 1211-1214, 1995.
6. KiP1 in human malignancies. Cancer Res 55: 2266-2269, 1995.
7. KiP1 gene in non- Hodgkin's lymphomas and adult T-cell leukemia/lymphoma. Blood 86: 1924-1930,1995.
8. KiP1 mutations found in breast cancer. Cancer Res 56: 2400-2404, 1996.
9. KiP1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nature Med 3: 222-225,1997.
10. Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup JM and Pagano M: Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in agressive colorectal carcinomas. Nature Med 3: 231-234, 1997.
11. Esposito V, Baldi A, De Luca A, Groger AM, Loda M, Giordano GG, Caputi M, Baldi F, Pagano M and Giordano A: Pronostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res 57: 3381-3385, 1997.
12. KiP1 is haplo-insufficient for tumour suppression. Nature 396: 177-180, 1998.
13. KiP1 to the confluence-dependent resistance of HT29 human colon carcinoma cells. Int J Cancer 77: 796-802, 1948.
14. Chauffert B, Dimanche-Boitrel M-T, Garrido C, Ivarsson M, Martin M, Martin F and Solary E: New insights into the kinetic resistance to anticancer agents. Cytotechnology 27: 225-235,1998.
15. KiP1 on resistance of tumor cells to anticancer agents. Nature Med 2: 1204-1210, 1996.
16. KiP1 induces drug resistance by preventing apoptosis upstream of cytochrome c release and procaspase-3 activation in leukaemic cells. Oncogene 18: 1411-1418, 1999.
17. Woodhouse JR and Ferry D: The genetic basis of resistance to cancer chemotherapy. Ann Med 27: 157-167,1995.
18. KiP1 overexpression causes apoptotic death of mammalian cells. Oncogene 15: 2991-2997, 1997.
19. Katayose Y, Kim M, Rakkar AN, Li Z, Cowan KH and Seth P: Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27. Cancer Res 57: 5441-5445, 1997.
20. KiP1. J Clin Invest 97: 1983-1988,1996.
21. KiP1 inhibits the growth of both normal and transformed human mammary epithelial cells. Cancer Res 58: 3448-3454,1998.
22. Orend G, Hunter T and Ruoslahti E: Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells. Oncogene 16: 2575-2583, 1998.